HFS
FLGT icon

Hantz Financial Services’s Fulgent Genetics FLGT Stock Holding History

Hantz Financial Services’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300
Closed -$7K – 1116
2024
Q1 		$7K Buy
300
+50
+20% +$1.24K ﹤0.01% 881
2023
Q4 		$7K Hold
250
– – ﹤0.01% 860
2023
Q3 		$7K Buy
250
+100
+67% +$3.41K ﹤0.01% 847
2023
Q2 		$6K Hold
150
– – ﹤0.01% 849
2023
Q1 		$5K Hold
150
– – ﹤0.01% 890
2022
Q4 		$4K Hold
150
– – ﹤0.01% 890
2022
Q3 		$6K Hold
150
– – ﹤0.01% 819
2022
Q2 		$8K Hold
150
– – ﹤0.01% 771
2022
Q1 		$9K Buy
+150
New +$9.88K ﹤0.01% 801

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hantz Financial Services's FLGT Position: Q2 2024 in Review

Hantz Financial Services sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 300 shares — an estimated $7K sold.

Hantz Financial Services first reported a position in FLGT in Q1 2022 and held it in 9 quarters. The position peaked at $9K in Q1 2022. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • Hantz Financial Services reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • Hantz Financial Services sold 300 Fulgent Genetics shares in Q2 2024, an estimated $7K.
  • Hantz Financial Services first reported a position in Fulgent Genetics in Q1 2022 and held it in 9 quarters.
  • Hantz Financial Services's Fulgent Genetics position peaked at $9K in Q1 2022.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on Hantz Financial Services's 13F filing for Q2 2024, filed 30 Jul 2024.